This study was designed to evaluate the zinc metabolism in adults of both sexes with thyroid disease. Plasma and erythrocyte zinc concentration and urinary zinc excretion were investigated. The mean concentration of plasma zinc in hypothyroid patients and in euthyroid patients, previously either hyperthyroid or hypothyroid, was lower than that of control subjects, whereas no statistically significant differences were observed in plasma zinc values between hyperthyroid patients and control subjects. The 
Introduction
Trace elements are known to influence hormones at several levels of action, including hormone secretion and activity and binding to target tissue. Conversely, hormones influence trace metal metabolism at several levels of action, including excretion and transport of trace metals (Henkin, 1976 (Henkin, 1976 
Results

Plasma zinc concentration
Relevant data for subjects grouped according to thyroid status are shown in Fig. 1 . No statistically significant differences were found in plasma zinc concentrations between patients with hyperthyroidism and control subjects, or between those with untreated hyperthyroidism and those with hyperthyroidism on treatment. The mean concentration of plasma zinc in patients previously hyperthyroid but now euthyroid was significantly lower than that for control subjects (P< 001) and that for patients with hyperthyroidism (P < 0-05).
The mean concentration of plasma zinc was found to be lower in hypothyroid patients and in patients previously hypothyroid but now euthyroid when compared with control subjects. There were no significant differences between hypothyroid patients and patients previously hypothyroid but now euthyroid.
Erythrocyte zinc concentration
As shown in Fig. 2 (Wolff, 1956) . However Bremner and Fell (1977) showed that plasma zinc concentrations in hyperthyroidism or in hypothyroidism were not different from those of healthy subjects. The present results on plasma zinc concentration in patients with overt hyperthyroidism demonstrated a similar pattern to that reported by Bremner and Fell (1977) . In contrast, however, this study indicates that plasma zinc concentrations in hypothyroid patients and in euthyroid patients, previously either hyperthyroid or hypothyroid, were significantly lower than those of control subjects and those of thyrotoxic patients.
Plasma zinc concentration does not always reflect the total body zinc status. Even in zinc-deficient patients the plasma zinc concentration may be normal. The corollary is also true in that hypozincaemia, such as that noted during acute infections and hypoproteinaemic states, and in women in late pregnancy and when taking oral contraceptives, may not reflect true zinc deficiency (Hambidge, 1977; Underwood, 1977) . (1974) demonstrated that erythrocyte zinc concentrations in hyperthyroidism were significantly lower than those in control subjects. The present study confirms these findings that red blood cell zinc concentration is decreased in patients with thyroid disease. Both zinc and carbonic anhydrase, which is by far the most abundant zinc metalloenzyme in erythrocytes, were decreased in hyperthyroidism (Pangaro et al., 1974; Seino et al., 1976) . This finding was considered to be possibly a specific action of thyroid hormones on carbonic anhydrase in erythrocytes. Moreover, exogenous thyroid hormones may also influence zinc metabolism, since patients with untreated hypothyroidism had a normal or rather higher zinc content of erythrocyte, but those with hypothyroidism on treatment and patients previously hypothyroid but now euthyroid had a lower erythrocyte zinc concentration.
The present investigation has shown a significantly higher zinc output in urine in thyrotoxic patients compared with euthyroid and hypothyroid patients and with control subjects, a similar pattern to that reported by Bremner and Fell (1977) . Higher urinary zinc excretion may result from an increased extracellular fluid zinc loss, but is not a renal phenomenon because of the increased zinc clearance and the increased ratio of zinc clearance:creatinine clearance in thyrotoxic patients (Bremner and Fell, 1977) .
Plasma zinc concentrations were maintained within normal limits in thyrotoxic patients despite the increased urinary losses; this may reflect the mobilization of zinc from tissue such as erythrocyte, bone and muscle by increased catabolism due to thyroid hormone excess (Fell et.al., 1973) .
Increased urinary zinc excretion has been observed in acromegaly, in which bone turnover may also be increased (Riggs et al., 1972) . Normally, a large percentage of the plasma zinc is bound to albumin. The albumin-bound zinc is in equilibrium with a small amino acid-bound fraction, and the latter is thought to be the major source of the zinc excreted in urine (Hambidge, 1977; Barness, 1978) . The alteration in equilibrium with amino acid-bound zinc due to the increased tissue breakdown may be another cause of hyperzincuria in thyrotoxic patients. Freely exchangeable zinc is complexed with micromolecular ligands, mainly the amino acids histidine and cysteine, and excreted via the kidney, but is present in the small fraction in plasma (Giroux and Henkin, 1972) . Therefore, the filtered load of zinc cannot be calculated simply on the basis of the total plasma zinc concentration as observed in hyperparathyroidism (Malette and Henkin, 1976 
